GR1007478B - Method for the collection of blood from placenta which is hematopoetic and mesenchymal stem cells. - Google Patents

Method for the collection of blood from placenta which is hematopoetic and mesenchymal stem cells.

Info

Publication number
GR1007478B
GR1007478B GR20100100605A GR20100100605A GR1007478B GR 1007478 B GR1007478 B GR 1007478B GR 20100100605 A GR20100100605 A GR 20100100605A GR 20100100605 A GR20100100605 A GR 20100100605A GR 1007478 B GR1007478 B GR 1007478B
Authority
GR
Greece
Prior art keywords
stem cells
placenta
blood
cell therapy
mesenchymal stem
Prior art date
Application number
GR20100100605A
Other languages
Greek (el)
Inventor
Γεωργιος Γεωργιου Κολιακος
Original Assignee
Γεωργιος Γεωργιου Κολιακος
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Γεωργιος Γεωργιου Κολιακος filed Critical Γεωργιος Γεωργιου Κολιακος
Priority to GR20100100605A priority Critical patent/GR1007478B/en
Publication of GR1007478B publication Critical patent/GR1007478B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The placenta consist a valuable source of stem cells for cell therapy and future application in the field of regenerative medicines because it contains multipotent cells which, under appropriate circumstances, could differentiate to several cellular populations. All the researches use enzymatic methods for the isolation of mesenchymal celjs from the placenta with reagents that have not been approved for therapeutic use in humans. For this reason they use small segments of the tissue. Other research teams use systems of placenta wash which are complicated and there is a high risk of contamination. In the present invention we describe a method which, in a short period of time, gives the potential to isolate mesenchymal stem cells and hematopoietic stem cells without the use of enzymatic separation, without additional microbial load and free of mother blood. The present invention relates to a closed system where an increased number of stem cells are isolated for use in cell therapy, including adult therapy.
GR20100100605A 2010-10-20 2010-10-20 Method for the collection of blood from placenta which is hematopoetic and mesenchymal stem cells. GR1007478B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20100100605A GR1007478B (en) 2010-10-20 2010-10-20 Method for the collection of blood from placenta which is hematopoetic and mesenchymal stem cells.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20100100605A GR1007478B (en) 2010-10-20 2010-10-20 Method for the collection of blood from placenta which is hematopoetic and mesenchymal stem cells.

Publications (1)

Publication Number Publication Date
GR1007478B true GR1007478B (en) 2011-12-13

Family

ID=45562582

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20100100605A GR1007478B (en) 2010-10-20 2010-10-20 Method for the collection of blood from placenta which is hematopoetic and mesenchymal stem cells.

Country Status (1)

Country Link
GR (1) GR1007478B (en)

Similar Documents

Publication Publication Date Title
Neri et al. Molecular mechanisms contributing to mesenchymal stromal cell aging
Scottà et al. Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4+ CD25+ FOXP3+ T regulatory cell subpopulations
Lelis et al. Myeloid-derived suppressor cells modulate B-cell responses
Yeo et al. Exosome: a novel and safer therapeutic refinement of mesenchymal stem cell
Che et al. Umbilical cord mesenchymal stem cells suppress B-cell proliferation and differentiation
Yang et al. Regulatory T cells inhibit microglia activation and protect against inflammatory injury in intracerebral hemorrhage
CY1123343T1 (en) GENERATION OF A BANK OF MESIJYMAL STRATIFIC CELLS FROM PLUGGED MONONUCLEAR CELLS OF MULTIPLE BONE MARROW DONORS
AR081166A1 (en) ANGIOGENESIS FOR THE USE OF PLACENTARY MOTHER CELLS
Slegtenhorst et al. Mechanisms and consequences of injury and repair in older organ transplants
SG10201808258SA (en) Improved methods for manufacturing adoptive cell therapies
BRPI0921799B8 (en) compounds that expand hematopoietic stem cells
BR112013002811A8 (en) simplified basic means for human pluripotent cell culture
BR112017018224A2 (en) Methods for Allogeneic T Cell Manipulation to Increase Persistence and / or Implantation in Patients
WO2012054792A3 (en) Composition and method for immunological treatment of cancer, prevention of cancer recurrence and metastasis, and overcoming immune suppressor cells
MX2016005824A (en) Cell culture method.
WO2012088225A3 (en) Method for identifcation and culture of multipotent mesenchymal stem cells with high proliferation potential
Franklin et al. Modulation and apoptosis of neutrophil granulocytes by extracorporeal photopheresis in the treatment of chronic graft-versus-host disease
Zhang et al. Effects of Rehmannia glutinosa oligosaccharide on human adipose-derived mesenchymal stem cells in vitro
IN2015DN01407A (en)
Dedeepiya et al. Index of CD34+ cells and mononuclear cells in the bone marrow of spinal cord injury patients of different age groups: a comparative analysis
WO2012164008A9 (en) Method of evaluation of the effect of nanoparticles on cell cultures
GR1007478B (en) Method for the collection of blood from placenta which is hematopoetic and mesenchymal stem cells.
Bao et al. Adaptive transfer of B10 cells: a novel therapy for chronic rejection after solid organ transplantation
WO2012050829A3 (en) Uses of il-12 and the il-12 receptor positive cell in tissue repair and regeneration
Kami et al. Cardiac mesenchymal progenitors from postmortem cardiac tissues retained cellular characterization

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20120206